Akèy › Maladi Dijestif › Nebraska
Etid klinik pou Maladi Dijestif nan Nebraska
3 etid pou Maladi Dijestif ap chèche patisipan nan sit nan Nebraska.
Tèks ofisyèl etid la (Anglè)
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
- Lied Transplant Center at Nebraska Medical Center, Omaha
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Sep 29, 2026 · NCT07197944Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Cancer Partners of Nebraska, Lincoln
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800Product Surveillance Registry
- Omaha
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.